The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central

Tilman Hottenrott1, Elisabeth Schorb2, Kristina Fritsch2

  • 1Department of Neurology and Neurophysiology, Faculty of Medicine, Medical Centre-University of Freiburg, Breisacher Straße 64, 79106, Freiburg, Germany. tilman.hottenrott@uniklinik-freiburg.de.

Journal of Neurology
|March 8, 2018
PubMed

Insights

The MRZ reaction (MRZR) in cerebrospinal fluid helps differentiate multiple sclerosis (MS) from primary central nervous system lymphoma (PCNSL). A positive MRZR indicates MS with high specificity, aiding in diagnosis.

Area of Science:

  • Neuroimmunology
  • Neurology
  • Oncology

Background:

  • Primary central nervous system lymphoma (PCNSL) can mimic multiple sclerosis (MS) in clinical presentation, MRI, and CSF findings.
  • The MRZ reaction (MRZR), assessing antibody indices against measles, rubella, and varicella zoster virus in CSF, is a specific marker for MS.

Purpose of the Study:

  • To evaluate the utility of a positive MRZ reaction (MRZR) and other routine cerebrospinal fluid (CSF) markers in distinguishing between MS and PCNSL.
  • To assess the diagnostic performance of MRZR using different antibody index (AI) thresholds.

Main Methods:

  • Retrospective analysis of CSF and brain biopsy data from 68 PCNSL patients.
  • MRZR determination in PCNSL patients (n=37), MS patients (n=74), and psychiatric disorder patients (n=78).
  • Application of two AI thresholds (≥1.5 and ≥2.0) for MRZR positivity (≥2 positive AIs).

Main Results:

  • Using an AI threshold of ≥1.5, MRZR was positive in 58.1% of MS patients versus 8.1% of PCNSL patients, yielding a positive predictive value (PPV) of 89.6%.
  • With a stricter AI threshold of ≥2.0, MRZR was positive in 37.8% of MS patients, while PCNSL and psychiatric disorder patients showed 0% positivity (100% PPV).
  • Quantitative intrathecal IgG synthesis was observed in 49.3% of MS patients but none of the PCNSL or psychiatric disorder patients.

Conclusions:

  • A positive MRZ reaction (MRZR) demonstrates high specificity and PPV for multiple sclerosis (MS), aiding in its differentiation from primary central nervous system lymphoma (PCNSL).
  • The MRZ reaction, particularly with a stricter antibody index threshold, is a valuable tool for distinguishing MS from PCNSL.
  • Intrathecal IgG synthesis is another reliable CSF marker that can help differentiate MS from PCNSL.